October 7, 2010Open Access
View Full Papern–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Key Points
Key points are not available for this paper at this time.
Abstract
Low-dose supplementation with EPA-DHA or ALA did not significantly reduce the rate of major cardiovascular events among patients who had had a myocardial infarction and who were receiving state-of-the-art antihypertensive, antithrombotic, and lipid-modifying therapy. (Funded by the Netherlands Heart Foundation and others; ClinicalTrials.gov number, NCT00127452.).